Skip to main content

Day: September 6, 2022

Daxor Corporation to Attend the H.C. Wainwright 24th Annual Global Investment Conference

Oak Ridge, TN, Sept. 06, 2022 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh will attend the H.C. Wainwright 24th Annual Global Investment Conference being held on September 12 – 14, 2022 at the Lotte New York Palace. Mr. Feldschuh will be available for one-on-one meetings. To request a meeting and to register for the conference, click: https://hcwevents.com/annualconference/ Interested investors may also contact Bret Shapiro at CORE IR either by calling 1-516-222-2560 or emailing brets@coreir.com. About Daxor Corporation Daxor Corporation (Nasdaq: DXR), is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100® (Blood Volume Analyzer),...

Continue reading

Gouverneur Bancorp, Inc. Announces Receipt of Regulatory Approvals for Acquisition of Citizens Bank of Cape Vincent and Expected Correction of Fiscal 2021 Financial Statements to Increase Net Income

GOUVERNEUR, N.Y., Sept. 06, 2022 (GLOBE NEWSWIRE) — Cambray Mutual Holding Company, Gouverneur Bancorp, Inc. (the “Company”) and Gouverneur Savings and Loan Association (collectively, “Gouverneur”) today announced that Gouverneur and Citizens Bank of Cape Vincent (“CBCV”) have received the requisite regulatory approvals necessary to complete Gouverneur’s acquisition of CBCV and merger of CBCV with and into Gouverneur Savings and Loan Association. The transaction is expected to close on September 16, 2022 and is subject to customary closing conditions. In addition, unrelated to its pending acquisition of CBCV, the Company also announced today that, in anticipation of the preparation of its financial statements for the fiscal year ending September 30, 2022, it has determined that its financial statements for the fiscal year ended...

Continue reading

CPI Aerostructures Reports First Quarter 2022 Results

First Quarter 2022 vs. First Quarter 2021Revenue of $20.1 million compared to $30.8 million; Gross profit of $3.4 million compared to $4.9 million; Gross profit margin of 17.1% compared to 16.0%; Net loss of $(32,931) compared to net income of $1.2 million (net income of $0.8 million excluding a $0.8 million severance accrual recorded during the first quarter of 2022); Loss per diluted share of $(0.00) compared to earnings per diluted share of $0.10 (earnings per diluted share of $0.06 excluding a $0.06 severance accrual recorded during the first quarter of 2022); Cash flow used in operations of $(2.4) million compared to a use of $(4.9) million; Debt as of March 31, 2022 of $25.3 million compared to $26.2 million as of December 31, 2021.EDGEWOOD, N.Y., Sept. 06, 2022 (GLOBE NEWSWIRE) — CPI Aerostructures, Inc. (“CPI Aero®”...

Continue reading

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2022 and Recent Developments

— Recorded First Quarter Revenue of $36.7 Million — — Signed $41 Million in Net New Business Orders and Ended the Quarter with a Record High Backlog of $157 Million — — Facilities and Capabilities Expansions in Mammalian and Cell and Gene Therapy Businesses Continue on Schedule — TUSTIN, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced financial results for the first quarter ended July 31, 2022. Highlights from the Quarter Ended July 31, 2022, and Other Events: “Following a very strong fiscal 2022, revenues in the first quarter...

Continue reading

GitLab Reports Second Quarter Fiscal Year 2023 Financial Results

Quarterly revenue of $101.0 million, up 74% year-over-yearAdded largest number of base customers ever in a single quarter Fiscal Second Quarter Highlights:Total revenue of $101.0 million GAAP operating margin of (65)%; Non-GAAP operating margin of (27)% GAAP net loss per share of $(0.40); Non-GAAP net loss per share of $(0.15)SAN FRANCISCO, Sept. 06, 2022 (GLOBE NEWSWIRE) — All-Remote – GitLab Inc. (NASDAQ: GTLB), The One DevOps Platform, today reported financial results for its second quarter fiscal year 2023, ended July 31, 2022. “We continue to see strong momentum in our business, and our second quarter results indicate that the market is embracing our One DevOps Platform leadership position,” said Sid Sijbrandij, GitLab CEO and Co-Founder. “Enterprises are navigating economic uncertainty while still needing to embrace...

Continue reading

Bassett Announces Purchase of Noa Home Inc.

BASSETT, Va., Sept. 06, 2022 (GLOBE NEWSWIRE) — Bassett Furniture Industries, Inc. (NASDAQ: BSET) announced today that it has acquired the capital stock of Noa Home Inc. (“Noa”), a mid-priced e-commerce furniture retailer headquartered in Montreal, Canada. Noa has operations in Canada, Australia, Singapore and the United Kingdom and had net revenues of approximately C$19.1 million for its most recent fiscal year. The purchase price included cash payments of C$2.0 million paid to the co-founders of Noa and approximately C$5.7 million for the repayment of existing debt. The Noa co-founders will also have the opportunity to receive additional annual cash payments of C$1.33 million per year for the following three fiscal years based on established increases in net revenues and achieving certain internal EBITDA goals. “We are excited...

Continue reading

HealthEquity Reports Second Quarter Ended July 31, 2022 Financial Results

Highlights of the second quarter include:Revenue of $206.1 million, an increase of 9% compared to $189.1 million in Q2 FY22. Net loss of $10.7 million, compared to $3.8 million in Q2 FY22, with non-GAAP net income of $28.1 million, a decrease of 16% compared to $33.4 million in Q2 FY22. Net loss per diluted share of $0.13, compared to $0.05 in Q2 FY22, with non-GAAP net income per diluted share of $0.33, compared to $0.40 in Q2 FY22. Adjusted EBITDA of $67.0 million, an increase of 2% compared to $65.5 million in Q2 FY22. 7.5 million HSAs, an increase of 26% compared to Q2 FY22. Total HSA Assets of $20.5 billion, an increase of 33% compared to Q2 FY22. 14.5 million Total Accounts, including both HSAs and complementary CDB accounts, an increase of 11% compared to Q2 FY22.DRAPER, Utah, Sept. 06, 2022 (GLOBE NEWSWIRE) — HealthEquity,...

Continue reading

Sack Lunch Announces Letter of Intent to Acquire Stake in Arowana Media Holdings

Two Media and Entertainment Companies to Join Forces in Rollup Strategy for Planned Expansion in the Digital Media and Entertainment MarketSack Lunch Announces Letter of Intent to Acquire Stake in Arowana Media Holdings AROWANA HOLDINGS – BE A PART OF THE NEXT BIG FILM FRANCHISESALT LAKE CITY, UTAH, Sept. 06, 2022 (GLOBE NEWSWIRE) — Sack Lunch Productions, Inc. (OTC PINK: SAKL), a publicly traded entertainment company with operations in event management and media productions, announced that it has signed a Letter of Intent to acquire 45% non-dilutive interest of Arowana Media Holdings Inc. (https://arowanamedia.com), a media and entertainment company focused on acquisition, development, and production of entertainment intellectual properties. Sack Lunch, an action-oriented events and entertainment company, acquires rights...

Continue reading

New Study Underscores Local Radio’s Impact for Political Candidates

Political Ads Tied to Local Radio Stations Perform Better AM/FM Radio Turns Out Swing Voters NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) — The Cumulus Media (NASDAQ: CMLS) | Westwood One Audio Active Group® (AAG) today released a brand-new analysis of two non-traditional creative approaches to political ads. The results showed that utilizing candidate-voiced ads in political campaigns and customizing political copy with station-specific verbiage that seeks input from listeners drove greater voter intent and were seen as more uplifting. The creative analysis reveals valuable insights and best practices for political audio campaigns. Some highlights include:Station-specific ads that call out the station call letters, fit the energy of the station, and seek to improve the campaign through soliciting feedback performed better than...

Continue reading

Ogilvy Health’s Kim Johnson Named a PharmaVoice 100 Honoree

Global CEO, Johnson to Serve as a Panelist During the Celebration’s Opening SessionKim Johnson: Global CEO – Ogilvy Health 2022 PharmaVoice 100 HonoreeNEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) — Ogilvy Health part of Ogilvy (www.ogilvy.com), today announced Kim Johnson, the agency’s Global CEO, has been named to the prestigious 2022 PharmaVoice 100, a recognition of the 100 most inspiring people in the life-sciences industry. Each year the PharmaVoice 100, established in 2005 by premier healthcare communications publication, PharmaVoice, honors select individuals for their inspirational contributions to the life sciences industry. The distinguished honorees are selected based on comprehensive testimonial essays detailing how nominated individuals have motivated and effected positive change within the healthcare marketing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.